SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of February, 2025
(Commission File No. 1-14862 )
BRASKEM S.A.
(Exact Name as Specified in its Charter)
N/A
(Translation of registrant's name into English)
Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ___X___ Form 40-F ______
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ______ No ___X___
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.
BRASKEM S.A.
National Register of Legal Entities (CNPJ) No. 42.150.391/0001-70
State Registration (NIRE) 29.300.006.939
a Publicly Held Company
MINUTES OF THE BOARD OF DIRECTORS’ MEETING
HELD ON JANUARY 30, 2025
1. DATE, TIME, AND PLACE: On January 30, 2025, at 9 am, at the offices of BRASKEM S.A. ("Braskem" or "Company"), located at Rua Lemos Monteiro, nº 120, 22nd floor, in the city of São Paulo, state of São Paulo, CEP 05501-050.
2. CALL NOTICE, ATTENDANCE AND PRESIDING BOARD: Extraordinary Meeting called pursuant to the Bylaws of the Company, with the attendance of all Board Members indicated below, whereby Danilo Ferreira da Silva and Roberto Faldini participated by teams. The Chief Executive Officer, Mr. Roberto Ramos, the Vice-President Geraldo Vilaça, Mr. André Montilha and Mrss. Lilian Porto Bruno, Clarisse Mello Machado Schlieckmann, Naiara Assad and Larissa Varella also were attending. The Chairman of the Board of Directors presided over the meeting, and Ms. Lilian Porto Bruno acted as secretary.
3. AGENDA, RESOLUTIONS AND SUBJECTS FOR ACKNOWLEDGEMENT OR OF INTEREST TO THE COMPANY:
3.1. RESOLUTION: After due analysis of the subject submitted for resolution, which the related materials was previously forwarded to the Board Members and shall remain duly filed at the Company’s Governance Portal, the following resolutions was taken:
(i) PD.CA/BAK-01/2025 – Definition of delegation limits for Contracting Loans, Financing, capital market transactions and other financial transactions by the Company's Executive Board: After the previous analysis by the Finance and Investment Committee ("CFI"), which issued an opinion favorably to its approval, the PD.CA/BAK-01/2025 was approved unanimously, in the sense of approving, for fiscal year 2025 and until the first Ordinary Meeting of the Board of Directors that takes place in fiscal year 2026, (a) the limit for the Board of Directors to contract loans, leasing, financing or capital market transactions, in the country or abroad, without the need for specific approval from the Board of Directors for each operation, whenever the applicable legislation or regulation does not require approval from the Board or from the Shareholders Meeting, in the amounts per operation of up to US$ 250 million for operations denominated in foreign currency and up to R$ 1.0 billion for operations denominated in Brazilian Reais, always observing, when the respective contract is signed, the Company's gross debt limit of US$ 9.5 billion, excluding the financing of Braskem Idesa and TQPM, as indicated in its last financial statement or quarterly information (ITR) disclosed to the market; (b) the contracting of guarantees, in the country or abroad, without the need for specific approval from the Board of Directors, which by operation imply the obligation to pay commissions in annual amounts of up to R$200 million; (c) the contracting of derivative operations, exchange contracts and discounting of receivables, in the country or abroad, without the need for specific approval from the Board of Directors for each operation, whenever the applicable legislation or regulation does not require approval from the Board or the Shareholders Meeting, in amounts per operation of up to US$250 million for operations denominated in foreign currency and up to R$1.0 billion for operations denominated in Brazilian Reais; established that the loans, financings or capital market operations contracted in fiscal year 2025 and until the first Ordinary Meeting of the Board of Directors that takes place in fiscal year 2026, with amounts, per operation, that exceed US$ 40 million for operations denominated in foreign currency and R$ 160 million for operations denominated in Brazilian Reais, must be periodically reported to the CFI, including the main terms and characteristics of such operations.
BRASKEM S.A.
National Register of Legal Entities (CNPJ) No. 42.150.391/0001-70
State Registration (NIRE) 29.300.006.939
a Publicly Held Company
MINUTES OF THE BOARD OF DIRECTORS’ MEETING
HELD ON JANUARY 30, 2025
3.2. Subjects for Acknowledgement: Nothing to record.
3.3. Subjects of Interest to the Company: Nothing to record.
4. ADJOURNMENT: As there were no further matters to be discussed, the meeting was closed and these minutes were drawn up, and, after being read, discussed, and found to be in order, were signed by all Board Members in attendance at the meeting, by the Chairman and by the Secretary of the Meeting.
São Paulo/SP, January 30, 2025.
José Mauro M. Carneiro da Cunha | Lilian Porto Bruno |
Chairman | Secretary |
Carlos Plachta | Danilo Ferreira da Silva |
Gesner José de Oliveira Filho | Héctor Nuñez |
João Pinheiro Nogueira Batista | Juliana Sá Vieira Baiardi |
Mauricio Dantas Bezerra | Olavo Bentes David |
Paulo Roberto Britto Guimarães | Roberto Faldini |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: February 10, 2025
| BRASKEM S.A. | |||
| By: | /s/ Felipe Montoro Jens | ||
| Name: | Felipe Montoro Jens | ||
| Title: | Chief Financial Officer | ||
DISCLAIMER ON FORWARD-LOOKING STATEMENTS
This report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are statements that are not historical facts, and are based on our management’s current view and estimates of future economic and other circumstances, industry conditions, company performance and financial results, including any potential or projected impact of the geological event in Alagoas and related legal proceedings and of COVID-19 on our business, financial condition and operating results. The words “anticipates,” “believes,” “estimates,” “expects,” “plans” and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the potential outcome of legal and administrative proceedings, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting our financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of our management and are subject to a number of risks and uncertainties, many of which are outside of the our control. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors, including the projected impact of the geological event in Alagoas and related legal proceedings and the unprecedented impact of COVID-19 pandemic on our business, employees, service providers, stockholders, investors and other stakeholders, could cause actual results to differ materially from current expectations. Please refer to our annual report on Form 20-F for the year ended December 31, 2019 filed with the SEC, as well as any subsequent filings made by us pursuant to the Exchange Act, each of which is available on the SEC’s website (www.sec.gov), for a full discussion of the risks and other factors that may impact any forward-looking statements in this presentation.